Status:
COMPLETED
Efficacy of Adhesive Strength of New Hydrogel Formulation
Lead Sponsor:
Firstkind Ltd
Conditions:
Stroke, Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will look at the stickiness of a new skin adhesive incorporated into a new next generation geko™ device called the geko™ X-T3 and compare it to the adhesive currently used into the geko™ T3 ...
Detailed Description
The new skin adhesive incorporated into the next generation geko™ device designated geko™ XT-3 has previously been tested to current international biocompatibility standards (ISO10993) , however the s...
Eligibility Criteria
Inclusion
- Male or female aged ≥ 18 years
- Currently an in-patient hospitalised for acute stroke
- Use of geko™ as a mechanical prophylaxis strategy for venous thromboembolism
- Patient understands and is willing to participate in the study and is able to comply with study procedures
Exclusion
- Pregnancy or breast feeding
- Use of any neuro-modulation device other than geko™
- Participation in any other clinical study that may interfere with the outcome of either study
Key Trial Info
Start Date :
July 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04309110
Start Date
July 13 2021
End Date
November 25 2021
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of North Midlands NHS Trust
Stoke-on-Trent, United Kingdom, ST4 6QG